T45G and G276T Adiponectin Gene Polymorphisms in Primary Aldosteronism and Healthy Controls in an East Slovak Population

Physiological Research

Volumn 62, Issue 4, 2013, Pages 413-420

  Jochmanova I ^a   Habalova V ^a   Wagnerova H ^a   Galovicova A ^a   Lazurova I ^a  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

Author keywords

Adiponectine gene polymorphism; Metabolic syndrome; Primary aldosteronism; Triglycerides

Indexed keywords

ADIPONECTIN; ADIPOQ PROTEIN, HUMAN; BIOLOGICAL MARKER; CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERALDOSTERONISM; MALE; MIDDLE AGED; PHENOTYPE; PREVALENCE; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SLOVAKIA; VERY ELDERLY;

ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHOLESTEROL; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERALDOSTERONISM; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS; SLOVAKIA; TRIGLYCERIDES;

EID: 84883512777     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. AL-DAGHRI NM, AL-ATTAS OS, ALOKAIL MS, ALKHARFY KM, HUSSAIN T, YAKOUT S, VINODSON B, SABICO S: Adiponectin gene polymorphisms (T45G and G276T), adiponectin levels and risk for metabolic diseases in an Arab population. Gene 493: 142-147, 2012.
2. BEEBE-DIMMER JL, ZUHLKE KA, RAY AM, LANGE EM, COONEY KA: Genetic variation in adiponectin (ADIPOQ) and the type 1 receptor (ADIPOR1), obesity and prostate cancer in African Americans. Prostate Cancer Prostatic Dis 13: 362-368, 2010.
3. BOSCARO M, RONCONI V, TURCHI F, GIACCHETTI G: Diagnosis and management of primary aldosteronism. Curr Opin Endocrinol Diabetes Obes 15: 332-338, 2008.
4. CUSPIDI C, MEANI S, FUSI V, SEVERGNINI B, VALERIO C, CATINI E, LEONETTI G, MAGRINI F, ZANCHETTI A: Metabolic syndrome and target organ damage in untreated essential hypertensives. J Hypertens 22: 1991-1998, 2004.
5. DEMIRCI H, YILMAZ M, ERGUN MA, YURTCU E, BUKAN N, AYVAZ G: Frequency of adiponectin gene polymorphisms in polycystic ovary syndrome and the association with serum adiponectin, androgen levels, insulin resistance and clinical parameters. Gynecol Endocrinol 26: 348-355, 2010.
6. EHRHART-BORNSTEIN M, ARAKELYAN K, KRUG AW, SCHERBAUM WA, BORNSTEIN SR: Fat cells may be the obesity-hypertension link: human adipogenic factors stimulate aldosterone secretion from adrenocortical cells. Endocr Res 30: 865-870, 2004.
7. ENNS JE, TAYLOR CG, ZAHRADKA P: Variations in adipokine genes AdipoQ, Lep, and LepR are associated with risk for obesity-related metabolic disease: the modulatory role of gene-nutrient interactions. J Obes 2011: 168659, 2011.
8. EXECUTIVE SUMMARY of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001.
9. FALLO F, VEGLIO F, BERTELLO C, SONINO N, DELLA MEA P, ERMANI M, RABBIA F, FEDERSPIL G, MULATERO P: Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab 91: 454-459, 2006.
10. FUNDER JW, CAREY RM, FARDELLA C, GOMEZ-SANCHEZ CE, MANTERO F, STOWASSER M, YOUNG WF, MONTORI VM: Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93: 3266-3281, 2008.
11. GONZALEZ-SANCHEZ JL, ZABENA CA, MARTINEZ-LARRAD MT, FERNANDEZ-PEREZ C, PEREZ-BARBA M, LAAKSO M, SERRANO-RIOS M: An SNP in the adiponectin gene is associated with decreased serum adiponectin levels and risk for impaired glucose tolerance. Obes Res 13: 807-812, 2005.
12. HANNEMANN A, WALLASCHOFSKI H: Prevalence of primary aldosteronism in patient's cohorts and in populationbased studies-a review of the current literature. Horm Metab Res 44: 157-162, 2012.
13. HARA K, BOUTIN P, MORI Y, TOBE K, DINA C, YASUDA K, YAMAUCHI T, OTABE S, OKADA T, ETO K, KADOWAKI H, HAGURA R, AKANUMA Y, YAZAKI Y, NAGAI R, TANIYAMA M, MATSUBARA K, YODA M, NAKANO Y, TOMITA M, KIMURA S, ITO C, FROGUEL P, KADOWAKI T: Genetic variation in the gene encoding adiponectin is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 51: 536-540, 2002.
14. HUANG MC, WANG TN, LEE KT, WU YJ, TU HP, LIU CS, CHIANG HC, KO YC: Adiponectin gene SNP276 variants and central obesity confer risks for hyperglycemia in indigenous Taiwanese. Kaohsiung J Med Sci 26: 227-236, 2010.
15. IACOBELLIS G, PETRAMALA L, COTESTA D, PERGOLINI M, ZINNAMOSCA L, CIANCI R, DE TOMA G, SCIOMER S, LETIZIA C: Adipokines and cardiometabolic profile in primary hyperaldosteronism. J Clin Endocrinol Metab 95: 2391-2398, 2010.
16. INADERA H: The usefulness of circulating adipokine levels for the assessment of obesity-related health problems. Int J Med Sci 5: 248-262, 2008.
17. IWASHIMA Y, KATSUYA T, ISHIKAWA K, OUCHI N, OHISHI M, SUGIMOTO K, FU Y, MOTONE M, YAMAMOTO K, MATSUO A, OHASHI K, KIHARA S, FUNAHASHI T, RAKUGI H, MATSUZAWA Y, OGIHARA T: Hypoadiponectinemia is an independent risk factor for hypertension. Hypertension 43: 1318- 1323, 2004.
18. JANG Y, LEE JH, CHAE JS, KIM OY, KOH SJ, KIM JY, CHO H, LEE JE, ORDOVAS JM: Association of the 276G→T polymorphism of the adiponectin gene with cardiovascular disease risk factors in nondiabetic Koreans. Am J Clin Nutr 82: 760-767, 2005.
19. KRUG AW, EHRHART-BORNSTEIN M: Adrenocortical dysfunction in obesity and the metabolic syndrome. Horm Metab Res 40: 515-517, 2008.
20. KYRIAKOU T, COLLINS LJ, SPENCER-JONES NJ, MALCOLM C, WANG X, SNIEDER H, SWAMINATHAN R, BURLING KA, HART DJ, SPECTOR TD, O'DELL SD: Adiponectin gene ADIPOQ SNP associations with serum adiponectin in two female populations and effects of SNPs on promoter activity. J Hum Genet 53: 718- 727, 2008.
21. LEE YY, LEE NS, CHO YM, MOON MK, JUNG HS, PARK YJ, PARK HJ, YOUN BS, LEE HK, PARK KS, SHIN HD: Genetic association study of adiponectin polymorphisms with risk of Type 2 diabetes mellitus in Korean population. Diabet Med 22: 569-575, 2005.
22. LI S, SHIN HJ, DING EL, VAN DAM RM: Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 302: 179-188, 2009.
23. MENZAGHI C, ERCOLINO T, SALVEMINI L, COCO A, KIM SH, FINI G, DORIA A, TRISCHITTA V: Multigenic control of serum adiponectin levels: evidence for a role of the APM1 gene and a locus on 14q13. Physiol Genomics 19: 170-174, 2004.
24. MENZAGHI C, TRISCHITTA V, DORIA A: Genetic influences of adiponectin on insulin resistance, type 2 diabetes, and cardiovascular disease. Diabetes 56: 1198-1209, 2007.
25. MOUSAVINASAB F, TAHTINEN T, JOKELAINEN J, KOSKELA P, VANHALA M, OIKARINEN J, KEINANENKIUKAANNIEMI S, LAAKSO M: Common polymorphisms (single-nucleotide polymorphisms SNP+45 and SNP+276) of the adiponectin gene regulate serum adiponectin concentrations and blood pressure in young Finnish men. Mol Genet Metab 87: 147-151, 2006.
26. MTIRAOUI N, EZZIDI I, TURKI A, CHAIEB A, MAHJOUB T, ALMAWI WY: Single-nucleotide polymorphisms and haplotypes in the adiponectin gene contribute to the genetic risk for type 2 diabetes in Tunisian Arabs. Diabetes Res Clin Pract 97: 290-297, 2012.
27. OHASHI K, OUCHI N, MATSUZAWA Y: Anti-inflammatory and anti-atherogenic properties of adiponectin. Biochimie 94: 2137-2142, 2012.
28. RONCONI V, TURCHI F, RILLI S, DI MATTIA D, AGOSTINELLI L, BOSCARO M, GIACCHETTI G: Metabolic syndrome in primary aldosteronism and essential hypertension: relationship to adiponectin gene variants. Nutr Metab Cardiovasc Dis 20: 93-100, 2010.
29. ROSSI GP: Prevalence and diagnosis of primary aldosteronism. Curr Hypertens Rep 12: 342-348, 2010.
30. SCHWARZ PE, GOVINDARAJALU S, TOWERS W, SCHWANEBECK U, FISCHER S, VASSEUR F, BORNSTEIN SR, SCHULZE J: Haplotypes in the promoter region of the ADIPOQ gene are associated with increased diabetes risk in a German Caucasian population. Horm Metab Res 38: 447-451, 2006.
31. ŠOMLóOVá Z, INDRA T, ROSA J, PETRáK O, ŠTRAUCH B, ZELINKA T, HOLAJ R, WIDIMSKÝ J JR: Have main types of primary aldosteronism different phenotype? Physiol Res 61: 431-436, 2012.
32. TSUZAKI K, KOTANI K, SANO Y, FUJIWARA S, GAZI IF, ELISAF M, SAKANE N: The relationship between adiponectin, an adiponectin gene polymorphism, and high-density lipoprotein particle size: from the Mima study. Metabolism 61: 17-21, 2012.
33. TURER AT, SCHERER PE: Adiponectin: mechanistic insights and clinical implications. Diabetologia 55: 2319-2326, 2012.
34. VOZAROVA DE COURTEN B, HANSON RL, FUNAHASHI T, LINDSAY RS, MATSUZAWA Y, TANAKA S, THAMEEM F, GRUBER JD, FROGUEL P, WOLFORD JK: Common polymorphisms in the adiponectin gene ACDC are not associated with diabetes in Pima Indians. Diabetes 54: 284-289, 2005.
35. WEYER C, FUNAHASHI T, TANAKA S, HOTTA K, MATSUZAWA Y, PRATLEY RE, TATARANNI PA: Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935, 2001.